Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |